Inve India ▾

Medplus Health Services share price & results

Medplus Health Services Limited· Consumer Services· Consumer Discretionary

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

India's 2nd-largest pharmacy retail chain, running 5,330+ neighbourhood stores plus diagnostics and omni-channel delivery.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue223 ₹ crore+21.2% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin13.0 %0.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit17.0 ₹ crore+21.4% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity11.36 %+3.1 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin5.41 %−2.4 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)16.79 %+3.2 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

4 of 8 judged targets kept · 5 open · verdicts reflect calls analysed to Q1 FY27.

Medplus Health Services Limited management guidance track record on Inve: 13 targets tracked across analysed earnings calls (4 achieved, 4 missed, 5 open).

TargetOriginal wordingSaidLatest callVerdict
Diagnostics Active PlansWe need the number to be closer to 250,000 for us to actually take the leap of expanding to other states
Call transcript, Q4 FY25 · 28 May 2025
Q4 FY25Q1 FY27:Active plans at ~200,000. Management stated they will not be expanding the diagnostics business significantly as it has not met expectations.
Call transcript, Q1 FY27 · 22 Jul 2026
Missed
Private Label Contribution Growththink about the private label as going up by roughly around 1% every quarter on the volume basis, which is on MRP basis
Call transcript, Q3 FY25 · 3 Feb 2025
Q3 FY25Q1 FY27:PL share contracted to 20% from 22% in Q4. Management revised growth target to 0.3-0.5% per quarter after arresting the decline.
Call transcript, Q1 FY27 · 22 Jul 2026
Revised Down
Net Store AdditionsI think it will be at least 600 stores for -- I don't think it will be less than 600 stores.
Call transcript, Q3 FY25 · 3 Feb 2025
Q3 FY25Q4 FY26:Achieved 618 net store additions for FY26
Call transcript, Q4 FY26 · 21 May 2026
Achieved

Source: Inve Guidance Tracker for Medplus Health Services Limited · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

4 of Medplus Health Services Limited's 13 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 10 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹608.15 +2.18% · +₹13

Last close 26 Oct 2026 · NSE · INR · Source: Inve

Performance −19.9% 1Y

₹600₹700₹800₹900Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 3 Nov 2025Q3 FY26 — 2 Feb 2026Q4 FY26 — 21 May 2026Q1 FY27 — 22 Jul 2026

1Y: ₹759 on 24 Oct 2025 → ₹608.15. High ₹953.9 (21 May 2026), low ₹594.7 (22 Oct 2026).

Previous close
₹595.15
Market cap
₹7.5k Cr
52-week range
₹594.7 – ₹953.9
One year
−19.79%
Price to earnings (TTM to Jun 2026)
35.34×
Return on equity (TTM to Jun 2026)
11.36%

Overview

Symbol
NSE:MEDPLUS
Industry
Consumer Discretionary
Exchange
NSE
Currency
INR

What Medplus Health Services Limited does

Based on the company's own presentations, annual report and earnings calls.

MedPlus operates a chain of neighbourhood pharmacy stores selling prescription and OTC medicines, wellness and FMCG products, layered with an omni-channel app for delivery and a diagnostics business. It earns through pharmacy and non-pharma retail sales at company-owned and franchisee-run stores, supplemented by a growing private-label range across pharma and non-pharma categories, and by diagnostics and optical service fees. Stores are organised in a cluster-based model backed by regional warehouses and distribution centres to enable same-day/2-hour delivery. The company also runs a technology subsidiary (Optival) supporting its omni-channel and supply-chain systems.

Segments

  • Pharmacy retail
  • Diagnostics
  • Franchisee stores
  • Others (Optical/membership)
Store network
5,330 stores
Geographic footprint
13 states and 1 union territory
Cities served
800+ cities
Total retail area
2.8 million+ sq ft (avg. ~528 sq ft/store)
Private-label SKUs
1,550+ SKUs (850+ pharma, 700+ non-pharma)
Total SKU range across warehouses
~50,000 SKUs
Founded 2006Headquarters Hyderabad, Telangana, IndiaEmployees 28,000 (Q4 FY2026 (Mar-2026)) Company website

How the price took the results

close before → close after

Q1 FY27
−12.8%
22 Jul
Q4 FY26
+4.7%
21 May
Q3 FY26
−0.1%
2 Feb
Q2 FY26
+7.5%
3 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Medplus Health Services Limited

Free account: one company. Everything above stays public.

Write why you follow Medplus Health Services Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds